Get the Stockscreener App
24.19
10.46%
2.29
After Hours:
24.40
0.21
+0.87%
Vera Therapeutics Inc stock is traded at $24.19, with a volume of 2.58M.
It is up +10.46% in the last 24 hours and up +17.20% over the past month.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
See More
Previous Close:
$21.90
Open:
$22.1
24h Volume:
2.58M
Relative Volume:
1.52
Market Cap:
$1.54B
Revenue:
-
Net Income/Loss:
$-107.85M
P/E Ratio:
-10.95
EPS:
-2.21
Net Cash Flow:
$-106.82M
1W Performance:
+11.78%
1M Performance:
+17.20%
6M Performance:
-19.26%
1Y Performance:
-36.61%
1-Day Range:
$21.96
$24.57
1-Week Range:
$21.64
$24.57
52-Week Range:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Name
Vera Therapeutics Inc
Sector
Industry
Phone
650-770-0077
Address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Compare VERA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
24.19 | 1.40B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| May-05-25 | Resumed | H.C. Wainwright | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Jan-28-25 | Initiated | Goldman | Buy |
| Nov-21-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jan-25-24 | Initiated | Oppenheimer | Outperform |
| Jan-08-24 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-18-23 | Initiated | Raymond James | Outperform |
| Nov-10-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-16-23 | Initiated | Guggenheim | Buy |
| Jan-04-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-04-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jul-12-22 | Initiated | JP Morgan | Overweight |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-22 | Initiated | Wedbush | Outperform |
View All
Vera Therapeutics Inc Stock (VERA) Latest News
Can trapped investors hope for a rebound in Vera Therapeutics Inc.Bull Run & Weekly High Momentum Picks - Newser
Published on: 2025-09-06 12:58:31 - Newser
How to build a dashboard for Vera Therapeutics Inc. stockMarket Weekly Review & Momentum Based Trading Ideas - Newser
Vera Therapeutics Inc. stock trendline breakdownJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - Newser
Chart based analysis of Vera Therapeutics Inc. trendsAnalyst Downgrade & Stock Portfolio Risk Control - Newser
Vera Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Should I average down on Vera Therapeutics Inc. stockMarket Growth Review & AI Powered Trade Plan Recommendations - خودرو بانک
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
85,000 Stock Options at $21.90: Vera Therapeutics Awards Inducement Grants to New Hires - Stock Titan
Is Vera Therapeutics Inc. forming a bottoming base2025 Dividend Review & Free Accurate Trade Setup Notifications - Newser
What’s next for Vera Therapeutics Inc. stock priceMarket Weekly Review & Verified Swing Trading Watchlist - Newser
Transcript : Vera Therapeutics, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 09 - MarketScreener
Long term hold vs stop loss in Vera Therapeutics Inc.2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
Institutional scanner results for Vera Therapeutics Inc.Market Movement Recap & Accurate Entry and Exit Point Alerts - Newser
What are Vera Therapeutics Inc.’s technical support levelsJuly 2025 Earnings & Comprehensive Market Scan Insights - خودرو بانک
Can Vera Therapeutics Inc. continue delivering strong returnsQuarterly Performance Summary & Technical Confirmation Trade Alerts - خودرو بانک
Why Vera Therapeutics Inc. is moving today2025 Key Lessons & Safe Entry Trade Signal Reports - Newser
Comparing Vera Therapeutics Inc. in custom built stock radarsWeekly Gains Report & Community Verified Trade Alerts - Newser
Best data tools to analyze Vera Therapeutics Inc. stock2025 Pullback Review & Stock Portfolio Risk Management - Newser
Strategies to average down on Vera Therapeutics Inc.Forecast Cut & Daily Risk Controlled Trade Plans - Newser
Using AI based signals to follow Vera Therapeutics Inc.July 2025 Movers & Breakout Confirmation Trade Signals - Newser
Will Vera Therapeutics Inc. rebound enough to break even2025 EndofYear Setup & Expert Verified Movement Alerts - Newser
How to recover losses in Vera Therapeutics Inc. stockEarnings Recap Summary & Reliable Entry Point Trade Alerts - Newser
When is the best time to exit Vera Therapeutics Inc.July 2025 Intraday Action & Fast Gain Stock Tips - Newser
Has Vera Therapeutics Inc. formed a bullish divergenceWeekly Trend Summary & Low Risk High Win Rate Stock Picks - Newser
Momentum divergence signals in Vera Therapeutics Inc. chartTrade Signal Summary & Low Risk Entry Point Guides - Newser
Signal strength of Vera Therapeutics Inc. stock in tech scanners2025 Top Decliners & Daily Profit Focused Screening - Newser
Volume spikes in Vera Therapeutics Inc. stock – what they mean2025 Market Trends & Detailed Earnings Play Strategies - Newser
Top chart patterns to watch in Vera Therapeutics Inc.Exit Point & AI Enhanced Trading Alerts - Newser
Price momentum metrics for Vera Therapeutics Inc. explainedMarket Growth Summary & Capital Protection Trading Alerts - Newser
Visual trend scoring systems applied to Vera Therapeutics Inc.July 2025 Fed Impact & Real-Time Market Trend Scan - Newser
Using AI based signals to follow Vera Therapeutics IncJuly 2025 Trade Ideas & Fast Gaining Stock Reports - Newser
Custom watchlist performance reports with Vera Therapeutics Inc.Weekly Gains Summary & High Conviction Trade Alerts - Newser
Does Vera Therapeutics Inc. have high return on assetsExit Point & Reliable Volume Spike Alerts - خودرو بانک
What high frequency data says about Vera Therapeutics Inc.July 2025 Momentum & Community Consensus Picks - Newser
Vera Therapeutics Inc Stock (VERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vera Therapeutics Inc Stock (VERA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):